-
Mashup Score: 0Dexcom, Abbott benefit from non-insulin, basal CGM user increase - 22 day(s) ago
William Blair analyst Margaret Kaczor reported surprise at the increase in users of CGM within the non-insulin and basal insulin populations.
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
The 2024 American Diabetes Association Standards of Care put an emphasis on getting continuous glucose monitoring into the hands of more people with diabetes. Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, a board-certified advanced diabetes manager, reviewed some of the biggest changes in the 2024 ADA Standards of Care during a poster presentation at the International Conference on
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 11
The 2024 American Diabetes Association Standards of Care put an emphasis on getting continuous glucose monitoring into the hands of more people with diabetes. Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, a board-certified advanced diabetes manager, reviewed some of the biggest changes in the 2024 ADA Standards of Care during a poster presentation at the International Conference on
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 11
The 2024 American Diabetes Association Standards of Care put an emphasis on getting continuous glucose monitoring into the hands of more people with diabetes. Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, a board-certified advanced diabetes manager, reviewed some of the biggest changes in the 2024 ADA Standards of Care during a poster presentation at the International Conference on
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Dexcom announces direct-to-watch feature for G7 CGM, strong automated insulin delivery outcomes - 2 month(s) ago
Dexcom (Nasdaq:DXCM) announced today that it introduced a direct-to-Apple-Watch feature for its G7 continuous glucose monitor (CGM) users.
Source: www.massdevice.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Time in range, other CGM metrics linked to diabetic retinopathy risk in type 1 diabetes - 4 month(s) ago
Providers can use continuous glucose monitoring metrics as well as HbA1c to assess diabetic retinopathy risk for adults with type 1 diabetes, according to findings published in Diabetes Technology & Therapeutics. “Our study confirms that time in range, as well as time in tight target range, is associated with incident diabetic retinopathy,” Viral N. Shah, MD, associate professor
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Time in range, other CGM metrics linked to diabetic retinopathy risk in type 1 diabetes - 4 month(s) ago
Providers can use continuous glucose monitoring metrics as well as HbA1c to assess diabetic retinopathy risk for adults with type 1 diabetes, according to findings published in Diabetes Technology & Therapeutics. “Our study confirms that time in range, as well as time in tight target range, is associated with incident diabetic retinopathy,” Viral N. Shah, MD, associate professor
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 2
People with diabetes using a 15-day continuous glucose monitor sensor can now integrate their CGM with an automated insulin delivery system, according to a press release. Tandem Diabetes Care’s t:slim X2 with Control-IQ insulin pump is the first automated insulin delivery system to integrate with the Abbott FreeStyle Libre 2 Plus sensor. The FreeStyle Libre 2 Plus sensor is a modified
Source: www.healio.comCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0Glucotrack has positive data for implantable blood glucose monitor - 4 month(s) ago
Glucotrack announced today that it completed the first preclinical study of its implantable continuous blood glucose monitor (CBGM).
Source: www.drugdeliverybusiness.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Abbott Diabetes Care CMO Mahmood Kazemi on expanding CGM access - 6 month(s) ago
Kazemi hopes anyone with diabetes will be able to access the technology, even people who don’t take insulin.
Source: www.medtechdive.comCategories: General Medicine News, Future of MedicineTweet
Non-insulin, basal #CGM use exceeds analysts’ expectations, @Dexcom and Abbott @FreeStyleLibre to benefit - nearly 300,000 new non-insulin CGM users, compared to a projection of 200,000 | #diabetes https://t.co/s93hRbNsoo